User Tools

Site Tools


asthma_adult

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
asthma_adult [2026/10/19 08:40] – [Manage in resus area for severe presentations] gary1asthma_adult [2026/10/19 11:20] (current) – [acute asthma in the adult patient] gary1
Line 19: Line 19:
     * Level 2: maintenance treatment with a low dose of inhaled steroid-formoterol, plus extra doses from same inhaler taken as needed for relief of symptoms (or salbutamol as reliever)     * Level 2: maintenance treatment with a low dose of inhaled steroid-formoterol, plus extra doses from same inhaler taken as needed for relief of symptoms (or salbutamol as reliever)
     * Level 3: maintenance treatment with a medium dose of inhaled steroid-formoterol (or higher number of inhalations using low-dose inhaler), plus extra doses from same inhaler taken as needed for relief of symptoms (or salbutamol as reliever)     * Level 3: maintenance treatment with a medium dose of inhaled steroid-formoterol (or higher number of inhalations using low-dose inhaler), plus extra doses from same inhaler taken as needed for relief of symptoms (or salbutamol as reliever)
-    * Level 4: more intensive regimens based on ICS-LABA, sometimes with add-on treatments such as long acting muscarinics (LAMAs) or monoclonal antibody therapies+    * Level 4: more intensive regimens based on ICS-LABA, sometimes with add-on treatments such as long acting muscarinics (LAMAs)(([[https://www.sciencedirect.com/science/article/pii/S1081120622000175|2022: Understanding the role of long-acting muscarinic antagonists in asthma treatment]])) or monoclonal antibody therapies
  
 =====introduction===== =====introduction=====
asthma_adult.txt · Last modified: by gary1

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki